Although crenezumab was not superior to placebo in individuals who are at high risk for Alzheimer s disease in the API ADAD Colombia Trial, results provide important data for future studies, experts say.
AC Immune SA (ACIU) Announces Detailed Data From the Phase II Crenezumab Alzheimer s Prevention Initiative Study in Autosomal Dominant Alzheimer s Disease Presented at AAIC streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Detailed Data From the Phase II Crenezumab Alzheimer s Prevention Initiative Study in Autosomal Dominant Alzheimer s Disease Presented at AAIC apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
AC Immune Holds Annual General Meeting of Shareholders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.